Coronary Allograft Vasculopathy – The Achilles' Heel of Heart Transplant – The Early Career Voice
Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant Recipients - ScienceDirect
Cardiac Allograft Vasculopathy: A Donor or Recipient Induced Pathology? | Journal of Cardiovascular Translational Research
Cardiac Allograft Vasculopathy: An Ongoing Challenge in the Care of Heart Transplant Recipients | IntechOpen
Sara Ward on X: "CAV is a recognized complication seen post-cardiac transplant and is amongst the top 3 causes of death after transplantation. Great information below regarding CAV prophylaxis for the heart
Implementing Coronary CT for Routine Annual Surveillance of Cardiac Allograft Vasculopathy in Heart Transplant Patients - The Journal of Heart and Lung Transplantation
Role of Quantitative Flow Ratio in Predicting Future Cardiac Allograft Vasculopathy in Heart Transplant Recipients | Circulation: Cardiovascular Interventions
Early Assessment of Cardiac Allograft Vasculopathy Risk Among Recipients of Hepatitis C Virus-infected Donors in the Current Era - Journal of Cardiac Failure
Diagnostics | Free Full-Text | The Role of Echocardiography in the Management of Heart Transplant Recipients
PET Assessment of Epicardial Intimal Disease and Microvascular Dysfunction in Cardiac Allograft Vasculopathy | Journal of the American College of Cardiology
Cardiac Allograft Vasculopathy: An Ongoing Challenge in the Care of Heart Transplant Recipients | IntechOpen
Transplantology | Free Full-Text | Multimodality Imaging to Detect Rejection, and Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients—An Illustrative Review
Established detection of CAV through its coronary sequelae. a An XRCA... | Download Scientific Diagram
Multiparametric Cardiac Magnetic Resonance Imaging Detects Altered Myocardial Tissue and Function in Heart Transplantation Recipients Monitored for Cardiac Allograft Vasculopathy